Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-19-000003

Options or other derivatives

  • Director acquired 50,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McKechnie William Edward Director 2019-04-05 Other acquisition · Stock Options +50,000 $1.53 $76,500 110,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…